Clinical Trials Sponsored by Dot Laboratories, Inc.

Total 391 results

Ranbaxy Laboratories Limited

Completed

Bioequivalence Study on Pseudoephedrine HCl 120 mg ER Tablets Under Fasting Conditions

Healthy

Canada
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Zolpidem 10 mg Tablets Under Fed Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Amoxicillin 400 mg/Clavulanic Acid 57 mg Chewable Tablets Under Fasting Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Fosinopril Sodium / Hydrochlorothiazide 20/ 12.5 mg Tablets Under Fed Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalecne Study of Minocycline 100mg Tablets Under Fed Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Glimepiride 1mg Tablets Under Fed Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study on Loratadine Orally Disintegrating Tablets 10 mg Under Fasting Conditions

Healthy
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Fosinopril 40mg Tablets Under Fed Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivaelnce Study of Doxycycline Monohydrate 100mg Tablets Under Fed Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Amlodipine 10mg Tablets Under Fed Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Doxycycline Monohydrate 100mg Tablets Under Fasting Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Clarithromycin 250mg Tablets Under Fasting Conditions

Healthy

India
Yale University
Ferndale Laboratories, Inc.

Completed

A Comparative Study of Occlusive Heat Patch in the Treatment of Warts

Verruca (Warts)

United States
Forest Laboratories
Cypress Bioscience, Inc.

Terminated

Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia (MyFi)

Primary Fibromyalgia

United States
Ironwood Pharmaceuticals, Inc.
Forest Laboratories

Completed

An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation

Irritable Bowel Syndrome With Constipation | Chronic Constipation

United States
AstraZeneca
Myriad Genetic Laboratories, Inc.

Withdrawn

Olaparib Maintenance Treatment Versus Placebo in Patients With PSR Ovarian Cancer Who Are in CR or PR to Platinum-based Chemotherapy and Whose Tumours Carry sBRCAm or HRR-associated Genes Mutations

Platinum Sensitive Relapsed Ovarian Cancer

United States, Korea, Republic of, Peru, United Kingdom, Philippines
Forest Laboratories
Ironwood Pharmaceuticals, Inc.

Completed

Safety and Efficacy of Linaclotide in Patients With Chronic Constipation and Prominent Abdominal Bloating

Constipation | Chronic Constipation

United States, Canada
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Minocycline HCl 135 mg ER Tablet Sunder Fed Conditions

Healthy
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Fenofibrate Capsules, 130 mg Under Fasting Conditions

Healthy
Ironwood Pharmaceuticals, Inc.
Forest Laboratories

Completed

Trial of Linaclotide in Patients With Chronic Constipation

Chronic Constipation

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Pantoprazole Sodium 40 mg Delayed Release Tablets Fasting Study

Healthy

India
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Donepezil Hydrochloride 10 mg Tablets Under Fasting Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

A Bioequivalence Study Of 80 Mg Atorvastatin Calcium Tablets Versus 80 Mg Lipitor® Tablets Under Fasting Conditions.

Healthy

United States
Ranbaxy Laboratories Limited

Completed

A Relative Bioavailability Study of Acetaminophen Extended Release Gel Tabs 650 mg Under Fed Condition

Healthy

India
Forest Laboratories
Cypress Bioscience, Inc.

Completed

Study of Milnacipran in Patients With Inadequate Response to Duloxetine for the Treatment of Fibromyalgia

Fibromyalgia

United States
NEMA Research, Inc.
Laboratories Carilene

Completed

Mentholated Cream Containing Oxygenated Glycerol Triesters on Acute Pain of the Muscles and Joints

Pain | Analgesics
Ranbaxy Laboratories Limited

Completed

A Relative Bioavailability Study of Valacyclovir Hydrochloride Tablets 1gm Under Fasting Condition

Healthy

India
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Risperidone 1 mg Orally-disintegrating Tablets Under Fed Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fasting Condition

Healthy

India
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Fluoxetine HCL 40 mg Capsules Under Fasting Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Topiramate Tablets 25mg Under Fed Conditions

Healthy

Canada
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Ramipril 10 mg Capsules Under Fasting Conditions

Healthy

India
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Quinapril Hydrochloride 20 mg and Hydrochlorothiazide 25 mg Tablets Under Fasting Conditions

Healthy

India
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Quinapril Hydrochloride 20 mg and Hydrochlorothiazide 25 mg Tablets Under Fed Conditions

Healthy

India
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Sumatriptan 100mg Tablets Under Fasting Conditions

Healthy

India
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Sertraline Hydrochloride 100mg Tablets Under Fed Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Zidovudine 300 mg Tablets, USP Under Fasting Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Metformin Hydrochloride Liquid 500mg/ 5 mL Under Fed Conditions

Healthy

Canada
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Pseudoephedrine HCl 120 mg ER Tablets Under Fed Conditions

Healthy

India
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Gabapentin 800 mg Tablets Under Fasting Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Amoxicillin-Clavulanic Acid 600 mg-42.9 mg/ 5 mL Oral Suspension Under Fed Conditions

Healthy

Canada
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Cefprozil 250 mg/ 5mL Powder For Oral Suspension Under Fasting Conditions

Healthy

Canada
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Cyclobenzaprine Hydrochloride 10 mg Tablets, USP Under Fasting Conditions

Healthy

India
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Cefprozil Tablets, USP 500 mg Under Fasting Conditions

Healthy

Canada
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Furosemide 80mg Tablets Under Fasting Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Cefprozil Tablets, USP 500 mg Undef Fed Conditions

Healthy

Canada
Ranbaxy Laboratories Limited

Completed

A Comparitive Bioavailability Study of Metformin Hydrochloride Liquid 500mg/ 5 mL Under Fasting Conditions and After Low and High Fat Meal

Healthy
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Benazepril HCl / Hydrochlorothiazide 20 mg/ 25 mg Tablets Under Fasting Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Cefprozil 250 mg/ 5mL Powder For Oral Suspension Under Fed Conditions

Healthy

Canada
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Amoxicillin 400 mg/Clavulanic Acid 57 mg Chewable Tablets Under Fed Conditions

Healthy

United States

3

Subscribe